Taysha Gene Therapies Inc

TSHA NASDAQ Healthcare & Biotech United States US8776191061
6.25 $
2.50 %

Taysha Gene Therapies Inc focuses on the development of gene therapies for the treatment of central nervous system diseases, including rare neurogenetic disorders.